San Diego-based mostly Viking Therapeutics marked alone as a serious competitor inside the weight loss drug sector in February right after revealing promising data from a mid-stage trial of experimental drug VK2735, which prompt it rivaled—and outperformed—Novo and Lilly drugs when given to be a weekly injection As well as in March the company